1. Home
  2. NEWT vs ENTA Comparison

NEWT vs ENTA Comparison

Compare NEWT & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NewtekOne Inc.

NEWT

NewtekOne Inc.

SELL

Current Price

$10.25

Market Cap

310.9M

Sector

Finance

ML Signal

SELL

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

SELL

Current Price

$8.70

Market Cap

303.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NEWT
ENTA
Founded
1998
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
310.9M
303.8M
IPO Year
2013
2012

Fundamental Metrics

Financial Performance
Metric
NEWT
ENTA
Price
$10.25
$8.70
Analyst Decision
Buy
Strong Buy
Analyst Count
7
6
Target Price
$15.20
★ $21.83
AVG Volume (30 Days)
227.8K
★ 237.5K
Earning Date
10-28-2026
11-16-2026
Dividend Yield
★ 7.25%
N/A
EPS Growth
11.22
★ 29.93
EPS
★ 1.24
N/A
Revenue
N/A
★ $102,814,000.00
Revenue This Year
$3.63
$0.53
Revenue Next Year
$10.99
$36.40
P/E Ratio
$8.47
★ N/A
Revenue Growth
N/A
★ 16.48
52 Week Low
$9.59
$10.01
52 Week High
$15.69
$17.15

Technical Indicators

Market Signals
Indicator
NEWT
ENTA
Relative Strength Index (RSI) 35.93 30.84
Support Level N/A N/A
Resistance Level $11.61 $13.94
Average True Range (ATR) 0.35 0.86
MACD -0.05 -0.09
Stochastic Oscillator 3.52 0.17

Price Performance

Historical Comparison
NEWT
ENTA

About NEWT NewtekOne Inc.

NewtekOne Inc provides business and financial solutions under the Newtek and NewtekOne brands to the independent business owner (SMB) market. Its services are offered online and in some cases delivered by staff via video and voice calls. The company offers lending products, FDIC insured deposit products and services, payments processing, payroll services and insurance brokerage services. Loan products include SBA 7(a), ALP, SBA 504, and traditional C&I and CRE bank loans, while deposit products include consumer high yield savings accounts, high yield certificates of deposit, zero-fee business checking and business money market accounts. The company operates through four reportable segments Banking, Alternative Lending, NSBF and Payments.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: